Survival Improvement over Time of 960 s-AML Patients Included in 13 EORTC-GIMEMA-HOVON Trials.

Ramadan, Safaa M; Suciu, Stefan; Stevens-Kroef, Marian J P L; Willemze, Roelof; Amadori, Sergio; de Witte, Theo; Löwenberg, Bob; Muus, Petra; Labar, Boris; Meert, Liv; de Schaetzen, Gaetan; Meloni, Giovanna; Leone, Giuseppe; Vignetti, Marco; Marie, Jean-Pierre; Lübbert, Michael; Baron, Frédéric

Ramadan, Safaa M; Suciu, Stefan; Stevens-Kroef, Marian J P L; Willemze, Roelof; Amadori, Sergio; de Witte, Theo; Löwenberg, Bob; Muus, Petra; Labar, Boris; Meert, Liv; de Schaetzen, Gaetan; Meloni, Giovanna; Leone, Giuseppe; Vignetti, Marco; Marie, Jean-Pierre; Lübbert, Michael; Baron, Frédéric.

Afiliação

Ramadan SM; EORTC Headquarter, 1200 Brussels, Belgium.
Suciu S; Currently in the Hemato-oncology Division, European Institute of Oncology, 20141 Milan, Italy.
Stevens-Kroef MJPL; Currently in the Department of Medical Oncology, NCI-Cairo University, 11796 Cairo, Egypt.
Willemze R; EORTC Headquarter, 1200 Brussels, Belgium.
Amadori S; Department of Human Genetics, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands.
de Witte T; Hematology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
Löwenberg B; Hematology, University Tor Vergata, 00133 Rome, Italy.
Muus P; Department of Hematology, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands.
Labar B; Hematology, Erasmus University Medical Center Rotterdam, 3000CA Rotterdam, The Netherlands.
Meert L; Department of Hematology, Radboud University Medical Centre, 6525 GA Nijmegen, The Netherlands.
de Schaetzen G; Department of Hematology, Kings College Hospital, London SE5 9RS, UK.
Meloni G; Department of Hematology, University Hospital Center Rebro, 10000 Zagreb, Croatia.
Leone G; EORTC Headquarter, 1200 Brussels, Belgium.
Vignetti M; EORTC Headquarter, 1200 Brussels, Belgium.
Marie JP; Department of Cellular Biotechnologies and Hematology, Sapienza University, 00161 Rome, Italy.
Lübbert M; Istituto di Ematologia, Università Cattolica S. Cuore, 00168 Rome, Italy.
Baron F; Data Center and Health Outcomes Research Unit, Italian Group for Adult Hematologic Diseases (GIMEMA), 00182 Rome, Italy.

Cancers (Basel) ; 12(11)2020 Nov 11.

Article em En | MEDLINE | ID: mdl-33187229

Palavras-chave

AML; secondary; trials

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Bélgica

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google